Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2016, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2016-09-19
DOI
10.1155/2016/6891482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
- (2015) F. McClanahan et al. BLOOD
- Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
- (2015) Sander Kelderman et al. CANCER CELL
- TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
- (2015) Claire Vanpouille-Box et al. CANCER RESEARCH
- PD-L1 expression in small cell lung cancer
- (2015) Takefumi Komiya et al. EUROPEAN JOURNAL OF CANCER
- Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy
- (2015) Mizuki Nishino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–PD-1 Therapy in Melanoma
- (2015) Blanca Homet Moreno et al. SEMINARS IN ONCOLOGY
- The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
- (2015) Xinbing Sui et al. Oncotarget
- PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
- (2015) R. W. Joseph et al. Cancer Immunology Research
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- PD-1 as an Immune Modulatory Receptor
- (2014) Sheng Yao et al. CANCER JOURNAL
- Immunological in vivo effects of B7-H1 deficiency
- (2014) Alexandr V. Bazhin et al. IMMUNOLOGY LETTERS
- Immunologic treatments for precancerous lesions and uterine cervical cancer
- (2014) Patrizia Vici et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer
- (2014) A. M. Heeren et al. Cancer Immunology Research
- The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients
- (2013) Zhifang Chen et al. Diagnostic Pathology
- Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
- (2013) Wen Yang et al. IMMUNOLOGY
- PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
- (2013) Bernd H. Zinselmeyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China
- (2013) ZHIFANG CHEN et al. Experimental and Therapeutic Medicine
- PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
- (2010) Feng Shi et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now